Exploration of the chemical space of benzamide-based voltage-gated potassium channel K v 1.3 inhibitors
Acta Pharmaceutica · 2025
DOI: 10.2478/acph-2025-0019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Pharmaceutica, 2025. Verfasst von Marzia Fois und 5 weiteren Autor:innen. Beteiligte Einrichtung: 1University of Ljubljana, Faculty of Pharmacy, 1000 Ljubljana, Slovenia. Hauptthemen laut MEDLINE: Kv1.3 Potassium Channel, Benzamides, Potassium Channel Blockers. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The voltage-gated potassium channel Kv1.3 is a key regulator of T-cell activation and a validated therapeutic target for autoimmune and inflammatory diseases. In this study, a ligand-based design strategy was employed to expand a library of benzamide-derived K v 1.3 inhibitors. Starting from a previously optimised thiophene-based inhibitor, structu ral modifications were introduced to the 2-methoxybenzamide moiety and the central tetrahydropyran or cyclohexane scaffold. A series of ketone, hydroxy, and carbamate derivatives was synthesised and evaluated for K v 1.3 inhibition using whole-cell patch-clamp electrophysiology. Structure-activity relationship analysis revealed that cis -isomers in the hydroxy series exhibited stronger activity than their trans counterparts, with some analogues displaying submicro-molar IC 50 values. In the carbamate series, trans -isomers were generally more potent, with trans - 18 and trans - 16 achieving IC 50 values of 122 and 166 nmol L–1, respectively. These results provide valuable insights into the design of K v 1.3 inhibitors and support further development of these compounds for immunomodulatory applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 1University of Ljubljana, Faculty of Pharmacy, 1000 Ljubljana, Slovenia.
- 2University of California, Davis Department of Pharmacology, Davis CA 95616, USA.
ORCID-Profile: Marzia Fois, Špela Pelcar, Heike Wulff, Lucija Peterlin Mašič, Tihomir Tomašič
Zitieren
APA
Fois, M., Pelcar, Š., Nasburg, J. A., Wulff, H., Mašič, L. P., & Tomašič, T. (2025). Exploration of the chemical space of benzamide-based voltage-gated potassium channel K v 1.3 inhibitors. Acta Pharmaceutica. https://doi.org/10.2478/acph-2025-0019
Vancouver
Fois M, Pelcar Š, Nasburg JA, Wulff H, Mašič LP, Tomašič T. Exploration of the chemical space of benzamide-based voltage-gated potassium channel K v 1.3 inhibitors. Acta Pharmaceutica. 2025. doi:10.2478/acph-2025-0019
BibTeX
@article{Fois2025,
author = {Fois, Marzia and Pelcar, Špela and Nasburg, Joshua A and Wulff, Heike and Mašič, Lucija Peterlin and Tomašič, Tihomir},
title = {Exploration of the chemical space of benzamide-based voltage-gated potassium channel K v 1.3 inhibitors},
journal = {Acta Pharmaceutica},
year = {2025},
doi = {10.2478/acph-2025-0019}
}
EUVIMED